Atezolizumab Market Report

Atezolizumab Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Mar 25, 2020
  • PAGES：188
  • REPORT CODE：GMM520276
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Atezolizumab market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.

    This report presents the market size and development trends by detailing the Atezolizumab market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Atezolizumab market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Atezolizumab industry and will help you to build a panoramic view of the industrial development.

    Atezolizumab Market, By Type:

    • Use: Single Drug

    • Use: Chemotherapy Combination

    Atezolizumab Market, By Application:

    • Bladder Cancer

    • Lung Cancer

    • Advanced Triple-negative Breast Cancer

    • Head and Neck Cancer

    • Urothelial Carcinoma

    • Renal Cell Carcinoma

    • Hepatocellular Carcinoma (HCC)

    • Other

    Some of the leading players are as follows:

    • Genentech (Roche)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Atezolizumab Market: Technology Type Analysis

    • 4.1 Atezolizumab Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Atezolizumab Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Use: Single Drug

      • 4.3.2 Use: Chemotherapy Combination

    5 Atezolizumab Market: Product Analysis

    • 5.1 Atezolizumab Product Market Share Analysis, 2018 & 2026

    • 5.2 Atezolizumab Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Atezolizumab Market: Application Analysis

    • 6.1 Atezolizumab Application Market Share Analysis, 2018 & 2026

    • 6.2 Atezolizumab Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Bladder Cancer

      • 6.3.2 Lung Cancer

      • 6.3.3 Advanced Triple-negative Breast Cancer

      • 6.3.4 Head and Neck Cancer

      • 6.3.5 Urothelial Carcinoma

      • 6.3.6 Renal Cell Carcinoma

      • 6.3.7 Hepatocellular Carcinoma (HCC)

      • 6.3.8 Other

    7 Atezolizumab Market: Regional Analysis

    • 7.1 Atezolizumab Regional Market Share Analysis, 2018 & 2026

    • 7.2 Atezolizumab Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Genentech (Roche)

      • 9.1.1 Genentech (Roche) Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

     

    The List of Tables and Figures (Totals 81 Figures and 162 Tables)

    • Figure Use: Single Drug Atezolizumab market, 2015 - 2026 (USD Million)

    • Figure Use: Chemotherapy Combination Atezolizumab market, 2015 - 2026 (USD Million)

    • Figure Bladder Cancer market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer market, 2015 - 2026 (USD Million)

    • Figure Advanced Triple-negative Breast Cancer market, 2015 - 2026 (USD Million)

    • Figure Head and Neck Cancer market, 2015 - 2026 (USD Million)

    • Figure Urothelial Carcinoma market, 2015 - 2026 (USD Million)

    • Figure Renal Cell Carcinoma market, 2015 - 2026 (USD Million)

    • Figure Hepatocellular Carcinoma (HCC) market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Atezolizumab market, by country, 2015 - 2026 (USD Million)

    • Table North America Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table North America Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table North America Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Canada Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Canada Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Europe Atezolizumab market, by country, 2015 - 2026 (USD Million)

    • Table Europe Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Europe Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Europe Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Germany Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Germany Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table France Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table France Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Italy Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Italy Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Spain Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Spain Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Atezolizumab market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table China Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table China Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Japan Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Japan Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table India Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table India Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Atezolizumab market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table MEA Atezolizumab market, by country, 2015 - 2026 (USD Million)

    • Table MEA Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table MEA Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table MEA Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Atezolizumab market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Atezolizumab market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Atezolizumab market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Genentech (Roche) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US